September 24, 2019
July 23, 2019
OnKure Executes License and Option Agreement with KDAc Therapeutics
June 11, 2019
OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179
May 06, 2019
OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179
May 02, 2018
OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug
